Novavax starts Covid-19 vaccine trials on children: United States biotech company Novavax said Monday it had actually begun professional tests of its suggested Covid-19 vaccine on kids, in a program that will involve up to 3,000 adolescents aged 12-17.
Much fewer children have actually been sick with Covid-19 compared to adults, and also the majority of have moderate to no symptoms, yet they can be contaminated and spread the virus.
Novavax claimed the trials would certainly test “the efficacy (as well as) safety and security” of the vaccine, with individuals getting either the vaccine candidate or placebo in 2 doses, 21 days apart.
Participants will be checked for up to 2 years after their injections.
The Novavax injection has actually not yet been authorized in any kind of country, including for adults, however the company plans to file for emergency authorization in Britain “in the second quarter of 2021”, complied with by in the United States.
Novavax announced at the end of January that scientific trials performed in Britain including 15,000 grownups showed 89.3 percent efficiency.
The Novavax injection, which utilizes various innovation from the doses already commonly accredited all over the world, is a protein-based injection engineered from the hereditary series of the first stress of the coronavirus.